Transfusion overuse under the knife
Transfusion overuse under the knife

Preserve the reserve

Health challenges such as the COVID-19 pandemic reinforce the need for patient blood management.

The COVID-19 pandemic has seen reductions in blood donation create a critical shortage in the blood supply. Around the world, experts have called for healthcare systems to reduce their dependency on blood transfusions and preserve the patients’ own blood.1

Preserve the reserve
Is a transfusion needed?

Is a transfusion needed?

Up to 60% of blood transfusions may be considered inappropriate3

Analysis of 450 typical inpatient medical, surgical, and trauma scenarios by an international multidisciplinary panel of 15 experts using the RAND/UCLA Appropriateness.3

How does your hospital compare?

How does your hospital compare?

There is wide variation in transfusion use between hospitals, and individual surgeons4–7

Considerable cost savings may be achieved if rates are reduced to exemplars.

Health Roundtable has analysed transfusion rates in key elective procedures in more than 200 hospitals in Australia and NZ.5

Patient blood management

Patient blood management

Patient blood management is an evidence-based bundle of care that
optimizes medical and surgical patient outcomes by clinically managing and preserving a patient’s blood

- Leahy et al. 20178

Patient blood management programs are associated with improved outcomes8,9

Patient blood management programs are associated with improved outcomes8,9
Patient blood management programs are associated with improved outcomes8,9
Patient blood management programs are associated with improved outcomes8,9

What can clinicians do to strike a balance between providing benefit for patients while avoiding risks of transfusion?

What can clinicians do to strike a balance between providing benefit for patients while avoiding risks of transfusion?

Minimise blood loss with adjunctive haemostats

Minimising blood loss is an essential part of patient blood management.3,4,8–12
Use of adjunctive haemostats can help reduce the risk of transfusions.13–22

*Results may vary by specific adjunctive haemostat used.

Minimise blood loss with adjunctive haemostats

Haemostasis Optimisation Program

Ethicon’s evidence-based, Haemostasis Optimisation Program offers a systematic approach to surgical bleeding. It provides guidance on selecting the right adjunctive haemostat for the right bleeding site and situation. The program has been proven to reduce surgical variation, maximise efficiency and improve outcomes.13

For further information, please contact your Ethicon representative.
*Results may vary by specific adjunctive haemostat used

Haemostasis Optimisation Program

Be part of the solution

Reduce the risk of blood transfusions with Ethicon’s broad portfolio of haemostats, designed to address a wide range of bleeding situations, including the three most common.13,23

Be part of the solution
Bleeding Matters

References

1. Shander AA et al. Anesth Analg. 2020;131(1):74–85.

2. Press release. Experts Underscore Essential Role for Patient Blood Management (PBM) in and beyond the COVID-19 Pandemic. https://pr.euractiv.com/pr/experts-underscoreessential-role-patient-blood-management-pbm-and-beyond-covid-19-pandemic (Accessed 25 November 2020).

3. Shander A et al. Transfus Med Rev. 2011;25(3):232‒246.e53.

4. National Blood Authority (NBA). Patient Blood Management Guidelines. Available at: www.blood.gov.au/pbm-guidelines (accessed July 2020).

5. Health Roundtable. National variation in RBC Transfusion Rate: How does your hospital compare? [Poster].

6. Goodnough LT et al. JAMA. 1991;265(1):86–90.

7. Qian F et al. Ann Surg. 2013;257(2):266–78.

8. Leahy MF et al. Transfusion. 2017;57(6):1347–58.

9. Althoff FC et al. Ann Surg. 2019;269(5):794–804.

10. Spahn DR and Goodnough LT. Lancet. 2013;381(9880):1855–65.

11. Hofmann A et al. Curr Opin Anaesthesiol. 2012;25(1):66–73.

12. Isbister JP. Best Pract Res Clin Anaesthesiol. 2013;27(1):69–84.

13. Ferko N et al. Healthcare Purchasing News. 2017;34–5.

14. Notarnicola A et al. Blood Coagul Fibrinolysis. 2012;23(4):278–84.

15. Levy J et al. Anesth Analg. 2010;110(2):354–64.

16. Molloy D et al. J Bone Joint Surg Br. 2010;89(3):306–9.

17. Sabatini L et al. J Orthop Traumatol. 2013;13(3):145–51.

18. Wang G et al. J Bone Joint Surg Am. 2001;83-A(10):1503–5.

19. Randelli F et al. Int J Immunopathol Pharmacol. 2013;26(1):189–97.

20. Liu L et al. PLoS One. 2013;8(5):e64261.

21. Massin P et al. Orthop Traumatol Surg Res. 2012;98(2):180–5.

22. Joseph T et al. Eur J Vasc Endovasc Surg. 2004;27(5):549–52.

23. Ethicon Haemostats. Product Information and Instructions for Use. Ethicon, Inc.